Qube Research & Technologies (QRT)’s Cullinan Therapeutics CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,936
Closed -$363K – 3711
2026
Q2
$363K Sell
19,936
-70,380
-78% -$1.05M ﹤0.01% 2742
2026
Q1
$1.28M Sell
90,316
-28,976
-24% -$372K ﹤0.01% 2384
2025
Q4
$1.23M Sell
119,292
-33,117
-22% -$299K ﹤0.01% 2467
2025
Q3
$904K Buy
152,409
+85,290
+127% +$625K ﹤0.01% 2564
2025
Q2
$505K Buy
+67,119
New +$539K ﹤0.01% 2689
2025
Q1
– Sell
-13,609
Closed -$166K – 3529
2024
Q4
$166K Buy
+13,609
New +$196K ﹤0.01% 2881
2024
Q3
– Sell
-190,520
Closed -$3.32M – 3397
2024
Q2
$3.32M Buy
190,520
+75,408
+66% +$1.61M 0.01% 1443
2024
Q1
$1.96M Buy
115,112
+108,266
+1,581% +$1.67M ﹤0.01% 1773
2023
Q4
$69.8K Buy
+6,846
New +$60.6K ﹤0.01% 3213
2022
Q2
– Sell
-16,628
Closed -$174K – 2555
2022
Q1
$174K Sell
16,628
-13,524
-45% -$183K ﹤0.01% 1978
2021
Q4
$465K Buy
+30,152
New +$601K ﹤0.01% 1607

Other funds holding CGEM

Qube Research & Technologies (QRT)'s CGEM Position: Q3 2026 in Review

Qube Research & Technologies (QRT) sold out of Cullinan Therapeutics (CGEM) in Q3 2026, closing a stake of 19,936 shares — an estimated $363K sold.

Qube Research & Technologies (QRT) first reported a position in CGEM in Q4 2021 and held it in 11 quarters. The position peaked at $3.32M in Q2 2024. 182 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

  • Qube Research & Technologies (QRT) reported no remaining Cullinan Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 19,936 Cullinan Therapeutics shares in Q3 2026, an estimated $363K.
  • Qube Research & Technologies (QRT) first reported a position in Cullinan Therapeutics in Q4 2021 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Cullinan Therapeutics position peaked at $3.32M in Q2 2024.
  • 182 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.